Public Profile

Fda

The FDA Group, commonly referred to as FDA, is a prominent consulting firm headquartered in the United States, with a strong presence in North America and Europe. Founded in 2003, the company has established itself within the regulatory affairs industry, specialising in assisting clients with FDA submissions, compliance strategies, and product development. FDA offers a range of core services, including regulatory consulting, quality assurance, and clinical trial management, which are tailored to meet the unique needs of the life sciences sector. Their expertise in navigating complex regulatory landscapes has positioned them as a trusted partner for pharmaceutical, biotechnology, and medical device companies. With a commitment to excellence, FDA has achieved notable milestones, including successful submissions for numerous high-profile products, solidifying its reputation as a leader in regulatory consulting.

DitchCarbon Score

How does Fda's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

9

Industry Benchmark

Fda's score of 3 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.

50%

Fda's reported carbon emissions

The FDA currently does not have publicly available carbon emissions data or specific reduction targets related to its climate commitments. Without concrete figures or initiatives outlined, it is unclear how the agency is addressing its carbon footprint or contributing to broader climate goals. The absence of emissions data suggests a need for enhanced transparency and accountability in their environmental strategies. As the FDA operates within the US, it is essential for the agency to align with industry standards and governmental climate initiatives to effectively manage and reduce its environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Fda's primary industry is Other business services (74), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Fda is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Fda is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Business Services

Matillion

GB
Business Services
Updated 11 days ago
CDP

Malakoff

MY
Business Services
Updated 11 days ago

Anxian Yuan China Holdings

HK
Business Services
Updated 11 days ago

RAFIAS INDUSTRIALES

MX
Business Services
Updated 6 days ago
UN

Innio

AT
Business Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers